Journal
EMBO MOLECULAR MEDICINE
Volume -, Issue -, Pages -Publisher
WILEY
DOI: 10.15252/emmm.202317570
Keywords
cell-to-cell communication; syntenin; tumor aggressiveness; tumor-stroma
Categories
Ask authors/readers for more resources
This study reveals a vicious signaling loop potentially at the heart of AML-stroma crosstalk and unexpected tumor-suppressive effects of syntenin that need to be considered during systemic targeting of syntenin in cancer therapy.
The crosstalk between cancer and stromal cells plays a critical role in tumor progression. Syntenin is a small scaffold protein involved in the regulation of intercellular communication that is emerging as a target for cancer therapy. Here, we show that certain aggressive forms of acute myeloid leukemia (AML) reduce the expression of syntenin in bone marrow stromal cells (BMSC). Stromal syntenin deficiency, in turn, generates a pro-tumoral microenvironment. From serial transplantations in mice and co-culture experiments, we conclude that syntenin-deficient BMSC stimulate AML aggressiveness by promoting AML cell survival and protein synthesis. This pro-tumoral activity is supported by increased expression of endoglin, a classical marker of BMSC, which in trans stimulates AML translational activity. In short, our study reveals a vicious signaling loop potentially at the heart of AML-stroma crosstalk and unsuspected tumor-suppressive effects of syntenin that need to be considered during systemic targeting of syntenin in cancer therapy.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available